AI model redefines multiple sclerosis as a continuum with dynamic stages instead of subtypes

Multiple sclerosis (MS) has long been regarded as a disease with different subtypes such as "relapsing" or "progressive." An international study, published on August 20, 2025, in Nature Medicine under the leadership of the Medical Center—University of Freiburg and the University of Oxford, challenges this dogmatic model after analyzing the NO.MS cohort (study data from Novartis).

👉 Full Story